NCT03705819View on ClinicalTrials.gov

Exploratory Evaluation of [11C]-NOP46

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 25, 2019

Primary Completion Date

October 30, 2023

Study Completion Date

October 30, 2023

Conditions
Chronic Pain
Interventions
DRUG

[11C]-NOP46

Subjects will receive a microdose (≤10 µg) of \[11C\]-NOP46.

RADIATION

PET/CT scan

After subjects receive a microdose of \[11C\]-NOP46, whole body PET/CT scan(s) will be performed to determine dosimetry and perform an initial safety evaluation of the radiotracer in Stage 1 and region of interests in Stage 2.

Trial Locations (1)

10032

Columbia University Irving Medical Center, New York

All Listed Sponsors
lead

Columbia University

OTHER

NCT03705819 - Exploratory Evaluation of [11C]-NOP46 | Biotech Hunter | Biotech Hunter